Boundless Bio, Inc. (BOLD)
NASDAQ: BOLD · IEX Real-Time Price · USD
9.67
+0.14 (1.47%)
May 16, 2024, 12:02 PM EDT - Market open
Boundless Bio Statistics
Total Valuation
Boundless Bio has a market cap or net worth of $209.86 million. The enterprise value is $105.94 million.
Market Cap | 209.86M |
Enterprise Value | 105.94M |
Important Dates
The last earnings date was Monday, May 13, 2024, before market open.
Earnings Date | May 13, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Boundless Bio has 22.25 million shares outstanding.
Shares Outstanding | 22.25M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 10.80% |
Owned by Institutions (%) | 39.78% |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.54
Current Ratio | 10.54 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$738,125 |
Employee Count | 72 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (1Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | n/a |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 40.22 |
Average Volume (30 Days) | 208,908 |
Short Selling Information
The latest short interest is 849,413, so 3.82% of the outstanding shares have been sold short.
Short Interest | 849,413 |
Short Previous Month | 513,700 |
Short % of Shares Out | 3.82% |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | n/a |
Pretax Income | n/a |
Net Income | -53.15M |
EBITDA | n/a |
EBIT | n/a |
Earnings Per Share (EPS) | -$2.39 |
Balance Sheet
The company has $105.44 million in cash and $1.52 million in debt, giving a net cash position of $103.92 million or $4.67 per share.
Cash & Cash Equivalents | 105.44M |
Total Debt | 1.52M |
Net Cash | 103.92M |
Net Cash Per Share | $4.67 |
Equity / Book Value | -141.18M |
Book Value Per Share | -6.34 |
Working Capital | 101.52M |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
Boundless Bio does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -25.32% |
FCF Yield | n/a |
Analyst Forecast
The average price target for Boundless Bio is $23.00, which is 137.85% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $23.00 |
Price Target Difference | 137.85% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |